Companies on Diabetes and Endocrinology

Published within

« | 1 | 2 | 3 | 4 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

OSI Pharmaceuticals, Inc.

OSI Pharmaceuticals (OSI) is a biotechnology company focused on the discovery, development and commercialization of molecular targeted therapies addressing unmet medical needs in oncology, diabetes and obesity. OSI primarily operates in the US. It is headquartered in Melville, New York and employs 535 people.

Published By MarketLine
28 Apr 2011 $175
Buy
Company Profile
Company Profile

Nycomed International Management GmbH

Nycomed International Management (Nycomed), a Takeda company, is engaged in the development and marketing of branded medicines primarily in the areas of gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. The company has operations in 50 countries worldwide. It primarily operates in Europe, the US, Latin America, South Africa, Canada and Russia. The company is headquartered in Zurich, Switzerland and employed 12,506 people as of December 31, 2010.

Published By MarketLine
20 Dec 2011 $175
Buy
Company Profile
Company Profile

Amylin Pharmaceuticals, LLC

Amylin Pharmaceuticals, LLC (Amylin or 'the company'), a wholly-owned subsidiary of Bristol-Myers Squibb (BMS), is a biopharmaceutical company engaged in the development of potential therapies to treat diabetes and obesity. Amylin currently markets Byetta, Symlin and Bydureon for the treatment of diabetes. The company primarily operates in the US, where it is headquartered in San Diego, California. It employed about 1,300 people as of December 31, 2011.

Published By MarketLine
08 Jan 2013 $175
Buy
Company Profile
Company Profile

Les Laboratoires Servier

Les Laboratoires Servier (Servier or 'the company') is the leading independent pharmaceutical company in France. The company focuses primarily in the therapeutic areas of neurosciences, oncology, cardiovascular disease, metabolic disease, rheumatology, and basic research. The company operates in 140 countries. It is headquartered in Neuily-Sur-Seine, France, and employs about 20,000 people.

Published By MarketLine
26 Jun 2013 $175
Buy
Company Profile
Company Profile

Sandoz International GmbH

Sandoz International GmbH (Sandoz or 'the company'), the generic business division of Novartis is engaged in the development, manufacture and marketing of generic medicines as well as pharmaceutical and biotechnological active ingredients. The company manufactures more complex generics in different delivery systems including patches, injectables and inhalers. It has operations in more than 140 countries. It is headquartered in Holzkirchen, Germany, and employed 25,835 people as of December 31, 2012.

Published By MarketLine
27 Aug 2013 $175
Buy
Company Profile
Company Profile

CJ CheilJedang Corp.

CJ CheilJedang Corp. (CJ CheilJedang or 'the company') is engaged in food, life science and logistics businesses. The company's product portfolio includes food ingredient and other food products such as sugar, flour, edible oil, seasonings, sauces, instant foods, instant cooked rice, fried dumplings, noodles and hams among others. CJ CheilJedang operates in Asia, Australia, the US, the Philippines and Brazil. It is headquartered in Jung-gu, South Korea, and employs about 4,514 people.

Published By MarketLine
12 Sep 2013 $175
Buy
Company Profile
Company Profile

Dyax Corporation

Dyax Corp. (Dyax or 'the company') is a development-stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapies that address unmet needs with an emphasis on inflammatory indications. The company is headquartered in Cambridge, Massachusetts, and employed 125 people as of February 01, 2013.

Published By MarketLine
20 Sep 2013 $175
Buy
Company Profile
Company Profile

Novartis AG

Novartis (or 'the company') is one of the Big Pharma companies having strong presence in diverse biopharmaceutical segments. It is engaged in the research, development, manufacture and marketing of branded drugs, generic pharmaceutical products, preventive vaccines, diagnostic tools and consumer health products. The company operates in more than 140 countries. It is headquartered in Basel, Switzerland, and employed 128,000 people as of December 31, 2012.

Published By MarketLine
26 Sep 2013 $175
Buy
Company Profile
Company Profile

Ipsen S.A.

Ipsen (or 'the group') is a global biopharmaceutical group with products in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The group primarily operates in Europe and North America. It is headquartered in Boulogne-Billancourt, France, and employed 4,835 people as of December 31, 2012.

Published By MarketLine
09 Oct 2013 $175
Buy
Company Profile
Company Profile

Kyowa Hakko Kirin Co., Ltd.

Kyowa Hakko Kirin (KHK or 'the group') is a Japan-based provider of pharmaceuticals and bio-chemicals. The group is a subsidiary of Kirin Holdings Company, which holds 52.75% of KHK's shares. The group is headquartered in Tokyo, Japan, and employed 7,243 people as on December 31, 2012.

Published By MarketLine
18 Oct 2013 $175
Buy

« | 1 | 2 | 3 | 4 | » »|

No help is available.